 |
FDA Approval Activities for this Drug
CHLOROTHIAZIDE Suspension; 250MG/5ML DIURIL MERCK
011145 CHLOROTHIAZIDE Tablet; 250MG DIURIL MERCK
011145 CHLOROTHIAZIDE Tablet; 500MG DIURIL MERCK
084388 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE Mylan
084217 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE Mylan
086028 CHLOROTHIAZIDE Tablet; 250MG CHLOROTHIAZIDE West Ward
087736 CHLOROTHIAZIDE Tablet; 500MG CHLOROTHIAZIDE West Ward
011145 CHLOROTHIAZIDE SODIUM Injection 500MG BASE/VIAL DIURIL MERCK
011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 250MG;0.125MG DIUPRES-250 MERCK
011635 BP CHLOROTHIAZIDE; RESERPINE Tablet; 500MG;0.125MG DIUPRES-500 | Diuril (chlorothiazide) Intravenous Injection Merck & Co., Inc, Labeling Revision
| Diuril (chlorothiazide) Oral Suspension Merck & Co., Inc, Labeling Revision
| Diuril (chlorothiazide) Tablets Merck & Co., Inc, Labeling Revision | Diruil (chlorothiazide) intravenous Injection and tablets, Merck & Co., Labeling Revision
For the most up-to-date approval information, please locate this API using the drug index.
|